Arriving in the field of obesity therapy, retatrutide is a distinct strategy. Beyond many current medications, retatrutide operates as a dual agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and https://henrioyjh708474.bloguerosa.com/37436574/the-innovative-retatrutide-a-glp-and-gip-sensor-agonist